Combined approach of carotid endarteriectomy and transcarotid transcatheter aortic valve implantation as a minimally invasive one-step treatment of aortic stenosis: a case report.

Aortic stenosis Case report Minimally invasive TAVI TAVR Transcarotid-TAVI

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
May 2023
Historique:
received: 05 07 2022
revised: 05 09 2022
accepted: 12 04 2023
medline: 14 5 2023
pubmed: 14 5 2023
entrez: 14 5 2023
Statut: epublish

Résumé

Despite the gold-standard approach for transaortic valve implantation (TAVI) remains transfemoral (TF), alternative approaches are needed in patients who present contraindications to transfemoral access. We report the case of a 79-year-old female with a symptomatic high-gradient severe aortic stenosis-mean gradient of 43 mmHg-and a significant supra-aortic trunk stenosis (left carotid artery: 90-99%; right carotid artery: 50-70%), and who was hospitalized for progressive dyspnoea New York Heart Association (NYHA) stage III. In this high-risk patient, it was decided to perform a TAVI. Because of a history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and stenotic thoraco-abdominal aorta atheromatosis, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a combined transcarotid-TAVI (TC-TAVI) with EDWARDS S3 23 mm valve with a left endarteriectomy during the same operating time. Our case illustrates an alternative approach to perform a percutaneous aortic valve implantation, despite supra-aortic trunk stenosis, in a high-risk surgical patient contraindicated to a TF-TAVI. Transcarotid transaortic valve implantation remains a safe alternative when TF-TAVI is contraindicated, and the combined approach of carotid endarteriectomy and TC-TAVI offers a minimally invasive one-step treatment in high operative risk patients.

Sections du résumé

Background UNASSIGNED
Despite the gold-standard approach for transaortic valve implantation (TAVI) remains transfemoral (TF), alternative approaches are needed in patients who present contraindications to transfemoral access.
Case summary UNASSIGNED
We report the case of a 79-year-old female with a symptomatic high-gradient severe aortic stenosis-mean gradient of 43 mmHg-and a significant supra-aortic trunk stenosis (left carotid artery: 90-99%; right carotid artery: 50-70%), and who was hospitalized for progressive dyspnoea New York Heart Association (NYHA) stage III. In this high-risk patient, it was decided to perform a TAVI. Because of a history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and stenotic thoraco-abdominal aorta atheromatosis, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a combined transcarotid-TAVI (TC-TAVI) with EDWARDS S3 23 mm valve with a left endarteriectomy during the same operating time.
Discussion UNASSIGNED
Our case illustrates an alternative approach to perform a percutaneous aortic valve implantation, despite supra-aortic trunk stenosis, in a high-risk surgical patient contraindicated to a TF-TAVI. Transcarotid transaortic valve implantation remains a safe alternative when TF-TAVI is contraindicated, and the combined approach of carotid endarteriectomy and TC-TAVI offers a minimally invasive one-step treatment in high operative risk patients.

Identifiants

pubmed: 37181472
doi: 10.1093/ehjcr/ytad184
pii: ytad184
pmc: PMC10171836
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytad184

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Références

Int J Cardiol. 2021 Mar 15;327:58-62
pubmed: 33242507
Circ J. 2018 Sep 25;82(10):2518-2522
pubmed: 30068794
J Cardiol. 2018 Jun;71(6):525-533
pubmed: 29499894
Indian J Thorac Cardiovasc Surg. 2019 Jan;35(1):55-58
pubmed: 33060970
Eur Heart J Case Rep. 2020 Nov 24;4(6):1-6
pubmed: 33447700

Auteurs

Baudouin Bourlond (B)

Department of Cardiology, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Filip Dulguerov (F)

Department of Cardiac Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Justine Longchamp (J)

Department of Vascular Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Matthias Kirsch (M)

Department of Cardiac Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Classifications MeSH